...

首页> 外文期刊>Journal of Hematology and Oncology >Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study

【24h】

Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study

机译：校正至：早期存在抗血管生成相关不良事件，作为使用阿帕替尼治疗的转移性胃癌患者抗肿瘤功效的潜在生物标志物：一项队列研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Hematology and Oncology》 |2018年第1期|共页
作者
Xinyang Liu; Shukui Qin; Zhichao Wang; Jianming Xu; Jianping Xiong; Yuxian Bai; Zhehai Wang; Yan Yang; Guoping Sun; Liwei Wang; Leizhen Zheng; Nong Xu; Ying Cheng; Weijian Guo; Hao Yu; Tianshu Liu; Pagona Lagiou; Jin Li;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety and effectiveness of apatinib in patients with previously treated metastatic gastric cancer: a sub-analysis from the real-world study of apatinib for gastric cancer treatment (AHEAD-G202) [J] . Xiang Wang, Zhanzhao Fu, Junmei Jia, American Journal of Cancer Research . 2020,第3期

机译：患有先前治疗的转移性胃癌患者的Apatinib的安全性和有效性：胃癌治疗的真实研究（前面G202）的实际研究中的分析
2. Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study [J] . Miaomiao Gou, Haiyan Si, Yong Zhang, Scientific reports. . 2018,第1期

机译：阿帕替尼对先前接受过治疗的转移性结直肠癌患者的疗效和安全性：一项现实世界的回顾性研究
3. Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study [J] . Miaomiao Gou, Haiyan Si, Yong Zhang, Scientific reports. . 2018,第1期

机译：阿帕替尼对先前接受过治疗的转移性结直肠癌患者的疗效和安全性：一项现实世界的回顾性研究
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study [O] . Xinyang Liu, Shukui Qin, Zhichao Wang, 2018

机译：校正至：早期存在抗血管生成相关不良事件作为使用阿帕替尼治疗的转移性胃癌患者抗肿瘤功效的潜在生物标志物：一项队列研究
7. Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study [O] . Xinyang Liu, Shukui Qin, Zhichao Wang, 2017

机译：早期存在抗血管生成相关不良事件作为apatinib治疗的转移性胃癌患者抗肿瘤疗效的潜在生物标志物：一项队列研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号